Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 177lu-617-prostate-specific Membrane Antigen Ligand
2. 177lu-psma-617
1. 177lu-psma-617
2. G6uf363ecx
3. Vipivotide Tetraxetan Lu-177
4. 177lu-labeled Psma-617
5. Lutetium Lu-177 Vipivotide Tetraxetan
6. Vipivotide Tetraxetan Lutetium Lu-177
7. Lutetium (177lu) Vipivotide Tetraxetan
8. Lutetium (177lu) Vipivotide Tetraxetan [inn]
9. Lutetium Lu 177 Vipivotide Tetraxetan [usan]
10. Pluvicto
11. Unii-g6uf363ecx
12. Who 11429
13. Lutetium (177lu) Vipivotide Tetraxetan [who-dd]
14. 1703749-62-5
15. 1983157-55-6
16. Lutetate(3-)-177lu, (n-((((1s)-1-carboxy-5-(((2s)-3-(2-naphthalenyl)-1-oxo-2-(((trans-4-(((2-(4,7,10-tris((carboxy-.kappa.o)methyl)-1,4,7,10-tetraazacyclododec-1-yl-.kappa.n1,.kappa.n4,.kappa.n7,.kappa.n10)acetyl-.kappa.o)amino)methyl)cyclohexyl)carbonyl)amino)propyl)amino)pentyl)amino)carbonyl)-l-glutamato(6-))-, Hydrogen (1:3)
17. Lutetate(3-)-177lu, (n2-((((1s)-1,3-dicarboxypropyl)amino)carbonyl)-n6-(3-(2-naphthalenyl)-n-((trans-4-(((2-(4,7,10-tris((carboxy-.kappa.o)methyl)-1,4,7,10-tetraazacyclododec-1-yl-.kappa.n1,.kappa.n4,.kappa.n7,.kappa.n10)acetyl-.kappa.o)amino)methyl)cyclohexyl)carbonyl)-l-alanyl)-l-lysinato(6-))-, Hydrogen (1:3
Molecular Weight | 1216.1 g/mol |
---|---|
Molecular Formula | C49H68LuN9O16 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 20 |
Rotatable Bond Count | 24 |
Exact Mass | 1215.42217 g/mol |
Monoisotopic Mass | 1215.42217 g/mol |
Topological Polar Surface Area | 374 Ų |
Heavy Atom Count | 75 |
Formal Charge | 0 |
Complexity | 1860 |
Isotope Atom Count | 1 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Treatment of PSMA-expressing prostate cancer
Radiopharmaceuticals
Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A 177 Lu-Labeled Psma-617 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 177 Lu-Labeled Psma-617, including repackagers and relabelers. The FDA regulates 177 Lu-Labeled Psma-617 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 177 Lu-Labeled Psma-617 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 177 Lu-Labeled Psma-617 supplier is an individual or a company that provides 177 Lu-Labeled Psma-617 active pharmaceutical ingredient (API) or 177 Lu-Labeled Psma-617 finished formulations upon request. The 177 Lu-Labeled Psma-617 suppliers may include 177 Lu-Labeled Psma-617 API manufacturers, exporters, distributors and traders.
click here to find a list of 177 Lu-Labeled Psma-617 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 177 Lu-Labeled Psma-617 DMF (Drug Master File) is a document detailing the whole manufacturing process of 177 Lu-Labeled Psma-617 active pharmaceutical ingredient (API) in detail. Different forms of 177 Lu-Labeled Psma-617 DMFs exist exist since differing nations have different regulations, such as 177 Lu-Labeled Psma-617 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 177 Lu-Labeled Psma-617 DMF submitted to regulatory agencies in the US is known as a USDMF. 177 Lu-Labeled Psma-617 USDMF includes data on 177 Lu-Labeled Psma-617's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 177 Lu-Labeled Psma-617 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 177 Lu-Labeled Psma-617 suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 177 Lu-Labeled Psma-617 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 177 Lu-Labeled Psma-617 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 177 Lu-Labeled Psma-617 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 177 Lu-Labeled Psma-617 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 177 Lu-Labeled Psma-617 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 177 Lu-Labeled Psma-617 suppliers with NDC on PharmaCompass.
177 Lu-Labeled Psma-617 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 177 Lu-Labeled Psma-617 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 177 Lu-Labeled Psma-617 GMP manufacturer or 177 Lu-Labeled Psma-617 GMP API supplier for your needs.
A 177 Lu-Labeled Psma-617 CoA (Certificate of Analysis) is a formal document that attests to 177 Lu-Labeled Psma-617's compliance with 177 Lu-Labeled Psma-617 specifications and serves as a tool for batch-level quality control.
177 Lu-Labeled Psma-617 CoA mostly includes findings from lab analyses of a specific batch. For each 177 Lu-Labeled Psma-617 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
177 Lu-Labeled Psma-617 may be tested according to a variety of international standards, such as European Pharmacopoeia (177 Lu-Labeled Psma-617 EP), 177 Lu-Labeled Psma-617 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (177 Lu-Labeled Psma-617 USP).
LOOKING FOR A SUPPLIER?